Measuring plasminogen activator inhibitor activity in plasma by two enzymatic assays.
We compared two methods that measure plasminogen activator inhibitor (PAI) activity in plasma based on the ability of PAI to inhibit tissue plasminogen activator (tPA) or urokinase (uPA) in order to determine which method most accurately measures plasma PAI activity after stressors, like hemorrhage. Plasma PAI activity was significantly elevated after hemorrhage in both assays. Using standard curves derived from rhPAI-1, we found that the tPA-PAI assay was more sensitive than the uPA-PAI assay. However, we measured a 10-fold difference in PAI activity as measured between assays, suggesting that some endogenous plasma constituents (tPA, uPA, plasminogen or plasmin) may interfere with the accurate determination of PAI activity. Increasing the amount of plasma in each assay led to a progressive increase in PAI activity. However, removing either tPA or plasminogen from the tPA-PAI assay unmasked the presence of some endogenous tPA and plasminogen. Furthermore, increasing plasma volume in either assay increases measured plasma tPA, but not uPA. Finally, plasma tPA is elevated after hemorrhage, whereas plasma uPA is not. These results suggest that endogenous tPA and plasminogen may interfere with the measurement of plasma PAI activity in the tPA-PAI assay after hemorrhage or other stresses. The uPA-PAI assay does not have this confounding problem because endogenous uPA does not interfere with the assay, nor does it rise during hemorrhage.
Chiu
W C
WC
Department of Surgery, University of Maryland School of Medicine, 10 South Pine Street, Room 400, Baltimore, MD 21201-1192, USA.
Gann
D S
DS
Darlington
D N
DN
D000818:Animals; D001774:Blood Chemical Analysis / Q000379:methods* / Q000592:standards; D003124:Colorimetry; D006470:Hemorrhage / Q000097:blood; D006801:Humans; D008297:Male; D015849:Plasminogen Inactivators / Q000097:blood* / Q000592:standards; D051381:Rats; D017207:Rats, Sprague-Dawley; D011994:Recombinant Proteins / Q000592:standards; D012015:Reference Standards; D010959:Tissue Plasminogen Activator / Q000037:antagonists & inhibitors; D014568:Urokinase-Type Plasminogen Activator / Q000037:antagonists & inhibitors
D015849:Plasminogen Inactivators; D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator